CHRISTINA BUGLIARELLO: Open Payments
NPI 1205603297 · CASA GRANDE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 31 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $142 |
| Astellas Pharma US Inc | 5 | $96 |
| GlaxoSmithKline, LLC. | 5 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Kestra Medical Technology Services, Inc. | 1 | $20 |
Products named: Veozah, VRAYLAR, CAPLYTA, TRELEGY ELLIPTA, UBRELVY, UNITHROID, Cologuard Collection Kit, Kerendia.
Industry payments across AZ — which companies pay providers there.
